Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Financial Incentives to Control Hypertension in Patients—Reply

Financial Incentives to Control Hypertension in Patients—Reply Letters Conflict of Interest Disclosures: The author has completed and submitted the COMMENT & RESPONSE ICMJE Form for Disclosure of Potential Conflicts of Interest and reported receiving income from consulting to Genentech. Financial Incentives to Control Hypertension 1. Petersen LA, Simpson K, Pietz K, et al. Effects of individual physician-level in Patients and practice-level financial incentives on hypertension care: a randomized trial. To the Editor In the trial reported by Dr Petersen and colleagues, JAMA. 2013;310(10):1042-1050. financial incentives to physicians and practice teams were 2. Petersen LA, Urech T, Simpson K, et al. Design, rationale, and baseline found to exert an “unexpectedly” impermanent effect on an characteristics of a cluster randomized controlled trial of pay for performance for hypertension treatment: study protocol. Implement Sci. 2011;6:114. outcome measure that combined blood pressure control with 3. Myers MG, Godwin M, Dawes M, et al. Conventional versus automated appropriate clinical response to uncontrolled blood pressure. measurement of blood pressure in primary care patients with systolic In their study protocol, Petersen et al indicated the com- hypertension: randomised parallel design controlled trial. BMJ. 2011;342:d286. bined measure would be used partly as a precaution against 4. Pickering TG, Hall JE, Appel LJ, et al; http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Financial Incentives to Control Hypertension in Patients—Reply

Petersen, Laura A.; Woodard, LeChauncy D.; Urech, Tracy H.
JAMA , Volume 311 (3) – Jan 15, 2014
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/financial-incentives-to-control-hypertension-in-patients-reply-LIpvi3eDuE

References (1)

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2013.284315
pmid
24430324
Publisher site
See Article on Publisher Site

Abstract

Letters Conflict of Interest Disclosures: The author has completed and submitted the COMMENT & RESPONSE ICMJE Form for Disclosure of Potential Conflicts of Interest and reported receiving income from consulting to Genentech. Financial Incentives to Control Hypertension 1. Petersen LA, Simpson K, Pietz K, et al. Effects of individual physician-level in Patients and practice-level financial incentives on hypertension care: a randomized trial. To the Editor In the trial reported by Dr Petersen and colleagues, JAMA. 2013;310(10):1042-1050. financial incentives to physicians and practice teams were 2. Petersen LA, Urech T, Simpson K, et al. Design, rationale, and baseline found to exert an “unexpectedly” impermanent effect on an characteristics of a cluster randomized controlled trial of pay for performance for hypertension treatment: study protocol. Implement Sci. 2011;6:114. outcome measure that combined blood pressure control with 3. Myers MG, Godwin M, Dawes M, et al. Conventional versus automated appropriate clinical response to uncontrolled blood pressure. measurement of blood pressure in primary care patients with systolic In their study protocol, Petersen et al indicated the com- hypertension: randomised parallel design controlled trial. BMJ. 2011;342:d286. bined measure would be used partly as a precaution against 4. Pickering TG, Hall JE, Appel LJ, et al;

Journal

JAMA – American Medical Association

Published: Jan 15, 2014

There are no references for this article.